Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.

2.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

3.

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

4.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

5.

Additional Proof of the Different Cognitive Effects of ARSIs for Prostate Cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot